, Tracking Stock Market Picks
Enter Symbol:
Cardiome Pharma Corporation (CRME) [hlAlert]

down 57.54 %

Cardiome Pharma Corporation (CRME) rated Outperform with price target $15 by Oppenheimer

Posted on: Monday,  Dec 1, 2008  9:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Cardiome Pharma Corporation (NASDAQ: CRME) on 12/01/2008, when the stock price was $20.75. Since
then, Cardiome Pharma Corporation has lost 57.54% as of 08/27/2015's recent price of $8.81.
If you would have followed this Oppenheimer's recommendation on CRME, you would have lost 57.54% of your investment in 2460 days.

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/1/2008 9:25 AM Buy
20.75 75.00
as of 12/24/2008
1 Week down  -8.23 %
1 Month down  -14.28 %
3 Months   
1 YTD down  -14.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy